Staff Reports
President Biden is putting the pedal to the metal on his “moonshot” initiative to tackle cancer head-on, now that he’s officially taken himself out of the 2024 race. With a personality that sometimes resembles a social media troll fresh off the internet, Biden trekked down to New Orleans to hype up a plan that promises to dramatically reduce cancer deaths. It’s almost like he’s trying to leave a tangible legacy, since his track record on tangible accomplishments has been weaker than a decaf coffee.
The president and his better half, First Lady Jill Biden, decided to visit Tulane University, where they announced the distribution of $150 million in funding through the Advanced Research Projects Agency for Health. This funding is set to support eight teams of researchers striving to improve tumor removal techniques. It’s a noble venture, but one can’t help but wonder if these funds might have been better spent combating the rising cost of living or solving the border crisis. Prioritizing cancer over the inflation-induced struggle millions face daily seems a touch out of touch.
Biden is announcing $150 million in research grants as part of his 'moonshot' push to fight cancer https://t.co/TymRjqRLsz pic.twitter.com/qeoh4F6RMZ
— WFLA NEWS (@WFLA) August 13, 2024
Biden has his sights set on a bold claim: a 50% reduction in U.S. cancer fatalities over the next 25 years. Achieving such a high bar might raise eyebrows, as experts suggest his lofty goal is only viable with “adequate investments.” It’s a classic “let’s throw some money at it” move—very reminiscent of strategies that haven’t worked out so well in the past. The American Cancer Society even chimed in, stating that while curing diseases once thought incurable is great, simply ensuring that people have access to existing treatments could already cut mortality rates by up to 30%. It’s a comforting thing to know that if people just had better access, we could do just fine.
Adding some personal flair, Biden’s motivation seems to come from family experiences with cancer, including the tragic loss of his son, Beau. That kind of pain drives one to fight for change. However, while Joe might be feeling the heat of his past personal losses, he’s got to be careful not to let those emotions cloud his judgment on what Americans really need. Spoiler alert: it’s not more government intervention in healthcare.
As Biden gears up for his final months in office, the question looms: Will tackling cancer really improve his legacy or serve merely as a distraction from the mounting chaos of his administration? Hopes for cancer treatments aside, the Biden administration’s record is as tangled as a yarn ball in the paws of a kitten. And with whispers about his political future being overshadowed by his current failures, maybe it’s time to stop focusing on unfulfilled promises and redirect attention toward real issues plaguing everyday Americans. It’s a nice gesture, where pie-in-the-sky aspirations cannot deny the dirt on the ground of reality. Wouldn’t it be refreshing if politicians made headlines for tangible results instead of lofty promises?
